Evidence map›Paper›PMID 42522162›Full record

ArticleThe American journal of case reports2026

Catheter-Directed Thrombolysis and Direct Oral Anticoagulant Class Switch to Prevent Pulmonary Embolism From Large Inferior Vena Cava Thrombus.

Takashi Araki, Kazuyuki Nishimura, Yusuke Hitora, Kenichiro Yokoi, Takashi Yamada, Manabu Miura

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Takashi ArakiDepartment of Cardiology, JA Aichi Kainan Hospital, Yatomi, Aichi, Japan.
Kazuyuki NishimuraDepartment of Cardiology, JA Aichi Kainan Hospital, Yatomi, Aichi, Japan.
Yusuke HitoraDepartment of Cardiology, JA Aichi Kainan Hospital, Yatomi, Aichi, Japan.
Kenichiro YokoiDepartment of Cardiology, JA Aichi Kainan Hospital, Yatomi, Aichi, Japan.
Takashi YamadaDepartment of Cardiology, JA Aichi Kainan Hospital, Yatomi, Aichi, Japan.
Manabu MiuraDepartment of Cardiology, JA Aichi Kainan Hospital, Yatomi, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Inferior vena cava (IVC) thrombosis is an uncommon complication of deep vein thrombosis and may be associated with a high risk of severe pulmonary embolism, particularly in the presence of free-floating thrombi. Although IVC filter placement may be considered to prevent embolization, prolonged filter dwell increases the risk of recurrent venous thrombosis and reduces retrieval success, highlighting the importance of early thrombus clearance. However, evidence regarding optimal interventional and anticoagulation strategies for IVC thrombosis remains limited. CASE REPORT A 46-year-old woman with Down syndrome and adjustment disorder presented with sudden-onset chest pain and syncope. On admission, she was hypotensive and hypoxemic. Contrast-enhanced computed tomography revealed bilateral pulmonary emboli and a large floating IVC thrombus extending from below the renal vein to the right common iliac vein. A retrievable IVC filter was placed, and anticoagulation was initiated. No underlying thrombophilia was identified. After 2 weeks, regression of the IVC thrombus was insufficient, and catheter-directed thrombolysis with alteplase and heparin was performed, resulting in marked clinical improvement. The patient was discharged on apixaban. After 2.5 months, the pulmonary arterial thrombi had resolved; however, the IVC thrombus persisted. Switching anticoagulation from apixaban to dabigatran led to complete thrombus resolution 4 months after symptom onset, allowing successful retrieval of the IVC filter. CONCLUSIONS This case highlights the potential role of alteplase-based catheter-directed thrombolysis for early thrombus reduction and suggests that switching from a factor Xa inhibitor to a direct thrombin inhibitor may be effective in select patients with refractory IVC thrombosis.

Indexed as

AnticoagulantsPulmonary EmbolismThrombolytic TherapyVena Cava, InferiorVenous ThrombosisFemaleFibrinolytic AgentsHumansMiddle AgedTissue Plasminogen ActivatorVena Cava FiltersAnticoagulantsFibrinolytic AgentsTissue Plasminogen Activator

Identifiers

PMID42522162
PMCPMC13431025

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.